Tegafur
Back to searchMolecule Structure
Scientific Name
Tegafur
Description of the Drug
Tegafur is an antineoplastic agent used in combination with other anticancer medications to treat advanced gastric and colorectal cancers.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09256
http://www.drugbank.ca/drugs/DB09256
Brand Name(s)
Citofur, Uftoral
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Thymidylate synthase | SINGLE PROTEIN | INHIBITOR | CHEMBL1952 |
| DNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2311221 |
| RNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2311222 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4552 | ||
| Human Metabolome Database | HMDB0246215 | ||
| DrugBank | DB09256 | ||
| PubChem: Thomson Pharma | 15195517 | ||
| PubChem | 5386 | ||
| Mcule | MCULE-1366455644 | ||
| LINCS | LSM-5155 | ||
| Nikkaji | J4.543H | ||
| EPA CompTox Dashboard | DTXSID8021305 | ||
| DrugCentral | 4398 | ||
| Brenda | 24420 | 30538 | 34913 |
| ChemicalBook | CB2419051 | ||
| Guide to Pharmacology | 10513 | ||
| rxnorm | TEGAFUR | ||
| KEGG Ligand | C12673 | ||
| ChEBI | 32188 |
